Sami Labs - Milestone

Message From Chairman

It is my firm belief that integration of modern scientific techniques into Ayurvedic herbal armamentarium can produce new drug molecules for India and for the world. A revisit into Ayurveda with the help of modern scientific approach from pharmaceutical era can produce very useful and safe products.

Details >>

	Milestones

2006

Awarded a product merit award by Nutrition Business Journal (NBJ) for the brand L- (+)

Selenomethionine compound, Selenium SeLECT ^®, and an Investment in Science and

Research award for ForsLean ^®.

Received the 17^th US Patent (US Patent # 6,99,8502) for the “A Convenient Process Of

Manufacture For Difluromethylornithine And Related Compounds

Received the 16^th US Patent (US Patent # 6,982,273) for the “Composition and methods

containing bioavailable Se-methyl-L-Selenochysteine for human and veterinary use

2005

Received the 4 ^th European Patent ( EP1341547) for the “Method of increased nutritional

and cosmetic compositions containing active ingredients from the liquid endosperm of fresh

green coconuts, and a method for obtaining the active ingredients

Sabinsa's US Patent (No 6,849,645 ) for Tetrahydropiperine received

Thomas Alva Edison Patent Award for 2005

Received the 14^th US Patent (US Patent # 6,849,645) for the “Method of increased

bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and

analogues and derivatives”.

Inaguaration of the new manufacturing facility at Kunigal, Karnataka

Sami Labs felicitated its outstanding Coleus cultivators at a function held at Attur in Salem

on18 June

Received the 3 ^rd European Patent ( EP0977564) for Forskolin for promoting Lean Body

Mass, shifting the proportion of mass in favor of lean body mass, reducing

fat tissue and encouraging weight loss.

Granted UK patent (GB 2380675) for “Method of increased bioavailability of nutrients and

pharmaceutical preparation with tetrahydropiperine and its analogues and derivatives”

2004

Sabinsa's US Patent (No5 ,804,596 ) for ForsLean ® received the Thomas Alva Edison

Patent Award for 2004

US patent #6,689,400 was issued for process of obtaining compositions of

stable lutein and lutein derivatives

US patent #6,794,537 was issued for manufacturing process for

Se- Methyl- L-Selenocysteine

2003

GarliSelect was introduced into the market

Mumbai office opened for marketing and co-ordination of clinical research

Cosmeceutical dosage forms developed for marketing – Johara TM Line of

Cosmeceuticals were born

US patent #6,607,712 was issued for Coleus Forskohlii oil for antimicrobial

properties

US patent #6,653,327 was issued for Tetrahydrocurcuminoids

MGP Herbal (P) Ltd was acquired by Sami Labs Ltd for fast tracking Herbal

Cultivation

2002

Super-Critical Fluid Extraction facility set up at Nelamangala, Bangalore

DSIR Award for R&D efforts

2001

The anti-obesity product Forslean ® was voted as the best product of the year

by Nutraceutical Industry Association – Nutracon in the US

European patent issued on Bioprotectant composition, method of use and

extraction process of Curcuminoids

Office opened in Japan for marketing

2000

Biotechnology Center established at Nelamangala, Bangalore

Introduced Cosmecutical ingredients

Tetrahydrocurcuminoids (White Turmeric) was introduced as a skin lightener into

the US market. It has become Sami's flagship cosmecutical product

1998

Coleus Forskohlii was introduced

It was accepted as a major product for improving body composition

US patent #5,804,596 for Forskohlin composition and use issued

Sami Chemicals and Extracts Pvt Ltd renamed as Sami Labs Limited

1997

New Jersey Technology Fast 50 Award

Sabinsa listed again in the Inc 500 companies, ranking # 90

Award for Export Performance for Spice products from President of India

Dr Raj Bammi joins as Director & President, Sami Labs Limited. Dr Bammi holds MS

and Ph.D from the University of California, California and has more than 25 years of

experience with a major pharma group.

1996

Sabinsa was listed in the Inc 500 companies, ranking # 70

First US patent awarded for the product Bioperine ®

A total Export-Oriented unit established at Kunigal, Bangalore

1995

Received Basic Drug Award from President of India .

1994

L-Selenomethionine introduced in India for the first time.

1995 – 1993

A number of products based on Indian herbal medicines were standardized by

Sami research group

1993

Manufacturing facility set up at Singasandra

Zinc Picolinate manufactured

1992

Hydroxycitric acid from Garcinia Cambogia, Citrin ® and Boswellia Serrata^®

were introduced and became a major export to the US by 1994.

R&D facility set up at Singasandra

1991

Sami Chemicals and Extracts Pvt Ltd set up in Bangalore

Sami started with the export of Gugulipid ® standardized extract